1. Home
  2. AGIO vs TDW Comparison

AGIO vs TDW Comparison

Compare AGIO & TDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • TDW
  • Stock Information
  • Founded
  • AGIO 2007
  • TDW 1956
  • Country
  • AGIO United States
  • TDW United States
  • Employees
  • AGIO N/A
  • TDW N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • TDW Marine Transportation
  • Sector
  • AGIO Health Care
  • TDW Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • TDW Nasdaq
  • Market Cap
  • AGIO 2.5B
  • TDW 2.9B
  • IPO Year
  • AGIO 2013
  • TDW N/A
  • Fundamental
  • Price
  • AGIO $24.46
  • TDW $52.48
  • Analyst Decision
  • AGIO Buy
  • TDW Hold
  • Analyst Count
  • AGIO 7
  • TDW 3
  • Target Price
  • AGIO $37.33
  • TDW $67.50
  • AVG Volume (30 Days)
  • AGIO 1.8M
  • TDW 892.9K
  • Earning Date
  • AGIO 10-30-2025
  • TDW 11-10-2025
  • Dividend Yield
  • AGIO N/A
  • TDW N/A
  • EPS Growth
  • AGIO N/A
  • TDW N/A
  • EPS
  • AGIO N/A
  • TDW 2.97
  • Revenue
  • AGIO $44,791,000.00
  • TDW $1,361,073,000.00
  • Revenue This Year
  • AGIO $25.57
  • TDW $0.68
  • Revenue Next Year
  • AGIO $153.24
  • TDW $5.02
  • P/E Ratio
  • AGIO N/A
  • TDW $17.66
  • Revenue Growth
  • AGIO 36.26
  • TDW 4.42
  • 52 Week Low
  • AGIO $22.24
  • TDW $31.17
  • 52 Week High
  • AGIO $62.45
  • TDW $64.07
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 25.59
  • TDW 47.23
  • Support Level
  • AGIO $22.24
  • TDW $52.49
  • Resistance Level
  • AGIO $46.00
  • TDW $59.60
  • Average True Range (ATR)
  • AGIO 2.20
  • TDW 3.25
  • MACD
  • AGIO -1.86
  • TDW 0.23
  • Stochastic Oscillator
  • AGIO 8.76
  • TDW 27.55

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

Share on Social Networks: